George L. Sing - 19 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/** George L. Sing
Issuer symbol
REGN
Transactions as of
19 Nov 2021
Net transactions value
-$1,970,000
Form type
4
Filing time
23 Nov 2021, 15:29:06 UTC
Previous filing
18 Nov 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $655,000 -1,000 -3% $655.00 31,858 19 Nov 2021 Direct
transaction REGN Common Stock Sale $655,000 -1,000 -3.1% $655.00 30,858 22 Nov 2021 Direct
transaction REGN Common Stock Sale $660,000 -1,000 -3.2% $660.00 29,858 22 Nov 2021 Direct
holding REGN Common Stock 750 19 Nov 2021 by Spouse
holding REGN Common Stock 400 19 Nov 2021 by Spouse/Cust Son
holding REGN Common Stock 1,000 19 Nov 2021 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.